Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | BRD4 | O60885 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MB | P02144 | 1/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | RARG | P13631 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1527112 | 0.86 | PKM (0.56) | PKMMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL23225814 | 0.84 | PKM (0.50) | PKMMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL6069339 | 0.84 | ERN1 (0.49) | MEN1MAPTKMT2AALDH1A1POLB | |
| SCHEMBL2560943 | 0.83 | ERN1 (0.59) | MEN1KMT2AALDH1A1CYP1A2ERN1 | |
| SCHEMBL17867196 | 0.83 | CYP3A4 (0.46) | MEN1MAPTKMT2AALDH1A1CA12 | |
| SCHEMBL10061909 | 0.82 | ALDH1A1 (0.50) | PKMMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL29953794 | 0.82 | ALDH1A1 (0.50) | PKMMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL3231550 | 0.81 | CYP3A4 (0.53) | MEN1MAPTKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL12511362 | 0.81 | ALDH1A1 (0.50) | MEN1MAPTKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL6558620 | 0.81 | RORC (0.49) | MEN1MAPTKMT2AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5786520-A | CATALYTIC VAPOR PHASE REACTION OF PHENOL COMPOUND WITH AN ALCOHOL | RHONE-POULENC CHIMIE (FR) | 1998-07-28 | — | — | US | claimed |
| EP-0599688-B1 | Process for O-alkylation of phenolic compounds | RHONE POULENC CHIMIE (FR) | 1997-08-27 | — | — | EP | claimed |
| EP-4703358-A1 | BENZO SIX-MEMBERED HETEROCYCLIC GSPT1 PROTEIN DEGRADATION AGENT AND USE THEREOF | China Pharmaceutical University (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-20250034091-A1 | Small molecule inhibitors of lanosterol synthase | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-01-30 | — | — | US | disclosed |
| CN-119136798-A | Small molecule lanosterol synthase inhibitors | 德克萨斯州立大学董事会 | 2024-12-13 | — | — | CN | disclosed |
| CN-111655665-B | Nitroolefin non-steroidal anti-inflammatory drugs (NA-NSAIDS) and methods of treating inflammation-related disorders | 蒙得维的亚巴斯德研究所 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024222918-A1 | BENZO SIX-MEMBERED HETEROCYCLIC GSPT1 PROTEIN DEGRADATION AGENT AND USE THEREOF | 中国药科大学 | 2024-10-31 | — | — | WO | disclosed |
| EP-3732162-B1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | INST PASTEUR DE MONTEVIDEO (UY) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023192782-A2 | SMALL MOLECULE INHIBITORS OF LANOSTEROL SYNTHASE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-10-05 | — | — | WO | disclosed |
| US-20210107860-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2021-04-15 | — | — | US | disclosed |
| US-20210107860-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2021-04-15 | — | — | US | disclosed |
| CN-1668595-A | Method for forming carbon-carbon or carbon-heteroatom bonds | RHONE POULENC CHIMIE (FR) | 2005-09-14 | — | — | CN | disclosed |
| CN-1217907-C | Method for preparing p-hydroxymandelic compounds optically substituted | PHODIA CHIMIE (FR) | 2005-09-07 | — | — | CN | disclosed |
| CN-1615284-A | Method for forming carbon-carbon bond or carbon-heteroatom bond | RHODIA CHIMIE SA (FR) | 2005-05-11 | — | — | CN | disclosed |
| US-20050065350-A1 | Method for forming a carbon-carbon or carbon-heteroatom linkage | SHASUN PHARMA SOLUTIONS, INC. | 2005-03-24 | — | — | US | disclosed |
| US-6753441-B1 | CONDENSING, IN WATER AND BASE, HYDROXYLATED AROMATIC COMPOUND WITH GLYOXYLIC ACID USING POLYCARBOXYLIC ACID CATALYST | RHODIA CHIMIE (FR) | 2004-06-22 | — | — | US | disclosed |
| US-20030236413-A1 | Catalysis in presence of a metallic element, an imine ligand and nitrogen compound as chelating compound, forming a chemical intermediates in the agrochemical and pharmaceutical fields | SHASUN PHARMA SOLUTIONS, INC. | 2003-12-25 | — | — | US | disclosed |
| US-20030171593-A1 | Process for arylating or vinylating or alkynating a nucleophilic compound | SHASUN PHARMA SOLUTIONS, INC. | 2003-09-11 | — | — | US | disclosed |
| CN-1320111-A | Method for preparing p-hydroxymandelic compounds optically substituted | PHODIA CHIMIE (FR) | 2001-10-31 | — | — | CN | disclosed |
| US-5786520-A | CATALYTIC VAPOR PHASE REACTION OF PHENOL COMPOUND WITH AN ALCOHOL | RHONE-POULENC CHIMIE (FR) | 1998-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065350-A1 | Method for forming a carbon-carbon or carbon-heteroatom linkage | COX6C, CBR3, CBR1 | PKM 1098/4885MEN1 4353/4885MAPT 3391/4885 |
| US-20030236413-A1 | Catalysis in presence of a metallic element, an imine ligand and nitrogen compound as chelating compound, forming a chemical intermediates in the agrochemical and pharmaceutical fields | ALK, INMT, ACHE | PKM 1333/4885MEN1 615/4885MAPT 3435/4885 |
| US-20250034091-A1 | Small molecule inhibitors of lanosterol synthase | LSS, CYP51A1, CYP27A1 | PKM 3941/4885MEN1 2088/4885MAPT 182/4885 |
| US-20210107860-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | PTGES, PTGS1, PTGIS | PKM 4053/4885MEN1 4684/4885MAPT 2965/4885 |
| US-20030171593-A1 | Process for arylating or vinylating or alkynating a nucleophilic compound | ALK, ALKBH3, NNMT | PKM 1946/4885MEN1 3899/4885MAPT 3262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.